Project Grant HT94252510735
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$466K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
The University of Wisconsin-Madison will receive $1.17 million over four years through a Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research to interrogate the intersection of prostate-specific membrane antigen and PI3K pathway signaling as a novel treatment approach for treatment-resistant prostate cancer. The University will investigate medical solutions for prostate cancer with the goals of transforming patient...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...
The University of Wisconsin-Madison will receive $1,377,598 under a three-year Project Grant from the Defense Health Agency to investigate medical solutions for targeting dysregulated histone-modifying enzymes driving prostate cancer cell survival after androgen deprivation therapy. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield...
This federal Project Grant award of $1,235,845.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research project led by the University of Illinois in Chicago. The project aims to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award period runs from August 15, 2025 to August 14, 2028. The Military Medical Research and Development program funds...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
This federal Project Grant award of $1,251,230.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a breast cancer research project with the University of Wisconsin System. The award will fund a clinical trial focused on breakthrough breast cancer treatments, with a performance period from June 2025 to June 2029. The University of Wisconsin System, a leading public research institution, will serve as the primary awardee and perform the...
This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research at the University of Kentucky Research Foundation focused on "Targeting MNK/GRP78 Pathway to Disrupt Proteostasis Rewiring in Castration-Resistant Prostate Cancer". The $1,602,137 award, spanning from April 2025 to April 2028, aims to investigate innovative medical solutions for military personnel and the broader...
The federal Project Grant award of $1,225,783 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. This research, conducted by the University of Colorado-Denver, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
This federal Project Grant award, with a funding amount of $231,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the award will fund research to develop AI-designed de novo miniproteins coupled with small molecules to initiate immune cell-mediated eradication of...
The federal Project Grant award of $1,198,659.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program will fund research at Northwestern University to evaluate disparities and improve the quality of prostate cancer detection for veterans through imaging. The award, which runs from July 1, 2025 to June 30, 2029, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public....